Eris Lifesciences Limited

NSEI:ERIS Stock Report

Market Cap: ₹188.7b

Eris Lifesciences Future Growth

Future criteria checks 4/6

Eris Lifesciences is forecast to grow earnings and revenue by 22.7% and 16% per annum respectively. EPS is expected to grow by 22.9% per annum. Return on equity is forecast to be 19.3% in 3 years.

Key information

22.7%

Earnings growth rate

22.9%

EPS growth rate

Pharmaceuticals earnings growth17.9%
Revenue growth rate16.0%
Future return on equity19.3%
Analyst coverage

Good

Last updated08 Oct 2024

Recent future growth updates

Recent updates

Eris Lifesciences Limited's (NSE:ERIS) CEO Compensation Looks Acceptable To Us And Here's Why

Sep 19
Eris Lifesciences Limited's (NSE:ERIS) CEO Compensation Looks Acceptable To Us And Here's Why

Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS) As Its Stock Soars 27%

Sep 03
Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS) As Its Stock Soars 27%

Earnings Update: Eris Lifesciences Limited (NSE:ERIS) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

Aug 05
Earnings Update: Eris Lifesciences Limited (NSE:ERIS) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly

Aug 04
Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly

Estimating The Intrinsic Value Of Eris Lifesciences Limited (NSE:ERIS)

Jul 13
Estimating The Intrinsic Value Of Eris Lifesciences Limited (NSE:ERIS)

Eris Lifesciences Limited (NSE:ERIS) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

May 24
Eris Lifesciences Limited (NSE:ERIS) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Why We're Not Concerned About Eris Lifesciences Limited's (NSE:ERIS) Share Price

May 10
Why We're Not Concerned About Eris Lifesciences Limited's (NSE:ERIS) Share Price

An Intrinsic Calculation For Eris Lifesciences Limited (NSE:ERIS) Suggests It's 25% Undervalued

Mar 14
An Intrinsic Calculation For Eris Lifesciences Limited (NSE:ERIS) Suggests It's 25% Undervalued

Analyst Estimates: Here's What Brokers Think Of Eris Lifesciences Limited (NSE:ERIS) After Its Third-Quarter Report

Feb 15
Analyst Estimates: Here's What Brokers Think Of Eris Lifesciences Limited (NSE:ERIS) After Its Third-Quarter Report

Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS)

Dec 28
Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS)

Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly

Dec 07
Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly

Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?

Nov 11
Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?

Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?

Jul 20
Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?

Does Eris Lifesciences (NSE:ERIS) Have A Healthy Balance Sheet?

Nov 20
Does Eris Lifesciences (NSE:ERIS) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Eris Lifesciences (NSE:ERIS) Is Using Debt Safely

Jun 20
These 4 Measures Indicate That Eris Lifesciences (NSE:ERIS) Is Using Debt Safely

A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)

Feb 24
A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)

Is Now The Time To Put Eris Lifesciences (NSE:ERIS) On Your Watchlist?

Dec 28
Is Now The Time To Put Eris Lifesciences (NSE:ERIS) On Your Watchlist?

Here's Why I Think Eris Lifesciences (NSE:ERIS) Might Deserve Your Attention Today

Sep 23
Here's Why I Think Eris Lifesciences (NSE:ERIS) Might Deserve Your Attention Today

If You Like EPS Growth Then Check Out Eris Lifesciences (NSE:ERIS) Before It's Too Late

May 26
If You Like EPS Growth Then Check Out Eris Lifesciences (NSE:ERIS) Before It's Too Late

Eris Lifesciences Limited (NSE:ERIS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Apr 17
Eris Lifesciences Limited (NSE:ERIS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Eris Lifesciences Limited's (NSE:ERIS) Stock Has Fared Decently: Is the Market Following Strong Financials?

Mar 12
Eris Lifesciences Limited's (NSE:ERIS) Stock Has Fared Decently: Is the Market Following Strong Financials?

Does Eris Lifesciences (NSE:ERIS) Deserve A Spot On Your Watchlist?

Feb 25
Does Eris Lifesciences (NSE:ERIS) Deserve A Spot On Your Watchlist?

Why Eris Lifesciences Limited (NSE:ERIS) Is A Dividend Rockstar

Feb 12
Why Eris Lifesciences Limited (NSE:ERIS) Is A Dividend Rockstar

Eris Lifesciences Limited (NSE:ERIS) Analysts Are Pretty Bullish On The Stock After Recent Results

Jan 30
Eris Lifesciences Limited (NSE:ERIS) Analysts Are Pretty Bullish On The Stock After Recent Results

Read This Before Buying Eris Lifesciences Limited (NSE:ERIS) Shares

Jan 17
Read This Before Buying Eris Lifesciences Limited (NSE:ERIS) Shares

Our View On Eris Lifesciences' (NSE:ERIS) CEO Pay

Dec 30
Our View On Eris Lifesciences' (NSE:ERIS) CEO Pay

Is Eris Lifesciences Limited's (NSE:ERIS) Recent Performance Tethered To Its Attractive Financial Prospects?

Dec 10
Is Eris Lifesciences Limited's (NSE:ERIS) Recent Performance Tethered To Its Attractive Financial Prospects?

Eris Lifesciences (NSE:ERIS) Shareholders Booked A 25% Gain In The Last Year

Nov 23
Eris Lifesciences (NSE:ERIS) Shareholders Booked A 25% Gain In The Last Year

Is It Worth Buying Eris Lifesciences Limited (NSE:ERIS) For Its 1.1% Dividend Yield?

Oct 22
Is It Worth Buying Eris Lifesciences Limited (NSE:ERIS) For Its 1.1% Dividend Yield?

Earnings and Revenue Growth Forecasts

NSEI:ERIS - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202738,1397,2069,451N/A7
3/31/202634,2525,6088,466N/A9
3/31/202530,2993,937-10,353N/A8
6/30/202422,4693,803N/AN/AN/A
3/31/202419,9133,9203,5684,860N/A
12/31/202318,4063,864N/AN/AN/A
9/30/202317,7503,856-3,3024,446N/A
6/30/202317,2983,824N/AN/AN/A
3/31/202316,6183,822-5,4972,917N/A
12/31/202215,6633,970N/AN/AN/A
9/30/202214,7663,9594192,844N/A
6/30/202213,7463,940N/AN/AN/A
3/31/202213,2624,0612,5723,783N/A
12/31/202112,9933,941N/AN/AN/A
9/30/202112,7633,8344,0584,428N/A
6/30/202112,4823,728N/AN/AN/A
3/31/202111,9263,5513,4963,754N/A
12/31/202011,6253,432N/AN/AN/A
9/30/202011,1923,1651,2112,724N/A
6/30/202010,7443,015N/AN/AN/A
3/31/202010,5822,9651,1992,712N/A
12/31/201910,2522,943N/AN/AN/A
9/30/201910,1193,1102,2192,599N/A
6/30/20199,9203,036N/AN/AN/A
3/31/20199,6722,9081,8502,230N/A
12/31/20189,8512,925N/AN/AN/A
9/30/20189,4422,870N/AN/AN/A
6/30/20189,2122,945N/AN/AN/A
3/31/20188,1962,941N/A2,346N/A
12/31/20178,0262,800N/AN/AN/A
9/30/20177,7812,735N/AN/AN/A
6/30/20177,2772,505N/AN/AN/A
3/31/20177,2052,468N/A2,002N/A
3/31/20165,9671,112N/A1,315N/A
3/31/20155,456892N/A901N/A
3/31/20145,088704N/A896N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ERIS's forecast earnings growth (22.7% per year) is above the savings rate (6.7%).

Earnings vs Market: ERIS's earnings (22.7% per year) are forecast to grow faster than the Indian market (17.3% per year).

High Growth Earnings: ERIS's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: ERIS's revenue (16% per year) is forecast to grow faster than the Indian market (10.2% per year).

High Growth Revenue: ERIS's revenue (16% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ERIS's Return on Equity is forecast to be low in 3 years time (19.3%).


Discover growth companies